HCW Biologics (HCWB) Financial Statements

206 Followers

HCW Biologics Financial Overview

HCW Biologics's market cap is currently $2.27M. The company's EPS TTM is $-1.02; its P/E ratio is -0.09; HCW Biologics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 54.23K	$ 2.57M	$ 2.84M	$ 6.72M	$ 0.00
Gross Profit	$ 10.85K	$ 959.40K	$ 560.36K	$ 2.59M	$ -543.60K
Operating Income	$ -11.26M	$ -29.48M	$ -25.72M	$ -15.08M	$ -13.37M
EBITDA	$ -5.67M	$ -27.68M	$ -23.58M	$ -14.06M	$ -12.32M
Net Income	$ -7.96M	$ -30.02M	$ -24.99M	$ -14.90M	$ -12.86M
Balance Sheet
Cash & Short-Term Investments	$ 1.95M	$ 4.67M	$ 3.60M	$ 32.06M	$ 36.71M
Total Assets	$ 24.52M	$ 30.24M	$ 28.51M	$ 46.81M	$ 53.51M
Total Debt	$ 6.81M	$ 13.69M	$ 6.30M	$ 6.41M	$ 0.00
Net Debt	$ 4.86M	$ 9.02M	$ 2.71M	$ -15.92M	$ -11.73M
Total Liabilities	$ 21.76M	$ 37.01M	$ 15.05M	$ 9.38M	$ 2.32M
Stockholders' Equity	$ 2.76M	$ -6.77M	$ 13.46M	$ 37.43M	$ 51.19M
Cash Flow
Free Cash Flow	$ -13.39M	$ -14.49M	$ -28.72M	$ -20.66M	$ -11.02M
Operating Cash Flow	$ -13.39M	$ -14.23M	$ -22.51M	$ -10.39M	$ -10.98M
Investing Cash Flow	$ 0.00	$ -261.62K	$ 3.80M	$ 14.71M	$ -35.02M
Financing Cash Flow	$ 10.67M	$ 15.57M	$ -14.53K	$ 6.27M	$ 49.27M

Currency in USD

HCW Biologics Earnings and Revenue History

Income Statement >

HCW Biologics Debt to Assets

Balance Sheet >

HCW Biologics Cash Flow

Cash Flow >

HCW Biologics Forecast EPS vs Actual EPS

Earnings >